We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+15.04%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$5.72B
AUM Growth
+$1.04B
Cap. Flow
+$416M
Cap. Flow %
7.27%
Top 10 Hldgs %
63.51%
Holding
50
New
7
Increased
15
Reduced
16
Closed
5

Top Buys

Rank Stock Value
1
CTVA icon
Corteva
CTVA
+$108M
2
ESI icon
Element Solutions
ESI
+$107M
3
ALIT icon
Alight
ALIT
+$91.6M
4
MRVL icon
Marvell Technology
MRVL
+$81.6M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$74.3M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$221M
2
THC icon
Tenet Healthcare
THC
+$127M
3
UBER icon
Uber
UBER
+$60M
4
AMZN icon
Amazon
AMZN
+$48.6M
5
CHTR icon
Charter Communications
CHTR
+$45.4M

Sector Composition

Rank Sector Weight
1 Healthcare 42.96%
2 Technology 19.46%
3 Materials 10.49%
4 Industrials 7.71%
5 Consumer Discretionary 5.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCA icon
26
HCA Healthcare
HCA
$88.5B
$65.2M 1.14%
195,585
-55,931
-22% -$17.1M
VTRS icon
27
Viatris
VTRS
$19B
$61.4M 1.07%
5,141,999
-923,048
-15% -$11.1M
META icon
28
Meta Platforms (Facebook)
META
$1.5T
$53.1M 0.93%
109,289
-47,851
-30% -$21.3M
BC icon
29
Brunswick
BC
$5.26B
$46.4M 0.81%
480,523
+119,846
+33% +$10.5M
DNB
30
DELISTED
Dun & Bradstreet
DNB
$36.2M 0.63%
3,609,884
-250,000
-6% -$2.73M
ARRY icon
31
Array Technologies
ARRY
$809M
$32.9M 0.57%
+2,204,685
New +$30.4M
DNA icon
32
Ginkgo Bioworks
DNA
$555M
$27.8M 0.49%
+600,000
New +$31.1M
AVGO icon
33
Broadcom
AVGO
$2T
$26.5M 0.46%
+200,270
New +$24.8M
EVLV icon
34
Evolv Technologies
EVLV
$1.07B
$26.5M 0.46%
5,947,937
+348,898
+6% +$1.51M
CAR icon
35
Avis
CAR
$4.89B
$22.2M 0.39%
+180,979
New +$25M
EXAS
36
DELISTED
Exact Sciences
EXAS
$15.7M 0.27%
+227,565
New +$14.4M
W icon
37
Wayfair
W
$14.3B
$14.9M 0.26%
+219,706
New +$12.4M
OFIX icon
38
Orthofix Medical
OFIX
$432M
$12.8M 0.22%
883,125
+383,125
+77% +$5.3M
BFLY icon
39
Butterfly Network
BFLY
$2.21B
$8.68M 0.15%
8,033,501
– –
DMRC icon
40
Digimarc Corp
DMRC
$171M
$7.93M 0.14%
291,855
– –
LBTYA icon
41
Liberty Global Class A
LBTYA
$3.68B
$2.98M 0.05%
176,110
– –
CBUS icon
42
Cibus
CBUS
$143M
$2.62M 0.05%
116,465
– –
RPID icon
43
Rapid Micro Biosystems
RPID
$104M
$1.28M 0.02%
1,318,288
– –
BFLY.WS
44
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$77.3K ﹤0.01%
1,713,333
– –
DOMA
45
DELISTED
Doma Holdings, Inc.
DOMA
$72.6K ﹤0.01%
15,994
– –
CAH icon
46
Cardinal Health
CAH
$55.7B
– –
-203,254
Closed -$20.5M
CHTR icon
47
Charter Communications
CHTR
$18.8B
– –
-116,933
Closed -$45.4M
CI icon
48
CALL
Cigna
CI
$72.7B
– –
-184,500
Closed -$55.2M
INTC icon
49
Intel
INTC
$503B
– –
-344,263
Closed -$17.3M
USFD icon
50
CALL
US Foods
USFD
$23.6B
– –
-250,000
Closed -$11.4M
1
2

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return

Glenview Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Glenview Capital Management held 50 positions worth $5.72B, up 22% from $4.68B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Glenview Capital Management deployed $416M of net new capital in Q1 2024, opening 7 new positions and adding to 15 existing holdings. Its largest new stake was Ginkgo Bioworks: 600,000 shares worth $27.8M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 45% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Cigna, an estimated $221M trimmed.

  • Glenview Capital Management's largest Q1 2024 buy was Ginkgo Bioworks: 600,000 shares worth $27.8M.
  • Glenview Capital Management added most to Corteva in Q1 2024, an estimated $108M increase.
  • Glenview Capital Management's biggest Q1 2024 reduction was Cigna, cutting an estimated $221M.
  • Glenview Capital Management fully exited Charter Communications in Q1 2024, selling an estimated $45.4M.
  • Glenview Capital Management's ten largest holdings make up 64% of its $5.72B portfolio in Q1 2024.
  • Glenview Capital Management opened 7 new positions and closed 5 in Q1 2024.
  • Glenview Capital Management's portfolio value rose 22% quarter-over-quarter to $5.72B.

Based on Glenview Capital Management's 13F filing for Q1 2024, filed 15 May 2024.